Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)

• Urvi M. Parikh ,

  * E-mail: ump3@pitt.edu

  Affiliation Department of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Photini Kiepiela,

  Affiliation HIV Prevention Research Unit, Medical Research Council, Durban, South Africa

  ⨯
• Shayhana Ganesh,

  Affiliation HIV Prevention Research Unit, Medical Research Council, Durban, South Africa

  ⨯
• Kailazarid Gomez,

  Affiliation FHI 360, Research Triangle Park, North Carolina, United States of America

  ⨯
• Stephanie Horn,

  Affiliation FHI 360, Research Triangle Park, North Carolina, United States of America

  ⨯
• Krista Eskay,

  Affiliation Department of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Cliff Kelly,

  Affiliation Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Barbara Mensch,

  Affiliation Population Council, New York, New York, United States of America

  ⨯
• Pamina Gorbach,

  Affiliation Department of Epidemiology, University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Lydia Soto-Torres,

  Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Gita Ramjee,

  Affiliation HIV Prevention Research Unit, Medical Research Council, Durban, South Africa

  ⨯
• John W. Mellors,

  Affiliation Department of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America

  ⨯
• on behalf of the IPTc Taskforce

  ¶Membership of the MTN-009 Protocol Team is provided in the Acknowledgments

  ⨯